QUALIFIED FOR TARGETED DRUG DELIVERY

NEUWAY Pharma GmbH

NEUWAY PHARMA GmbH is a preclinical biotech company based in Bonn, Germany. The company is focusing on the preclinical development of innovative therapeutics for treatment of brain diseases based on its proprietary Drug Delivery Technology so-called EnPC®.

NEUWAY had been founded in April 2014 as the first spin-off from Life Science Inkubator (LSI) GmbH, Bonn, Germany, where it had been incubated and supported.

The company was seeded by Wellington Partners, LSI, Kreditanstalt für Wiederaufbau (KfW) and several private shareholders. In total NEUWAY raised 17.4 Mio.€, funded with 9.2 Mio.€ in a series A round; extended by convertible loans with 8.2 Mio.€.

 

Neuway had been founded in April 2014